Zacks: Analysts Expect LifePoint Health, Inc. (LPNT) Will Announce Quarterly Sales of $1.60 Billion
Equities research analysts expect LifePoint Health, Inc. (NASDAQ:LPNT) to report sales of $1.60 billion for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for LifePoint Health’s earnings. The lowest sales estimate is $1.58 billion and the highest is $1.61 billion. LifePoint Health reported sales of $1.59 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 0.6%. The company is scheduled to announce its next quarterly earnings report on Friday, October 27th.
According to Zacks, analysts expect that LifePoint Health will report full-year sales of $1.60 billion for the current year, with estimates ranging from $6.44 billion to $6.49 billion. For the next year, analysts expect that the business will report sales of $6.61 billion per share, with estimates ranging from $6.48 billion to $6.72 billion. Zacks’ sales averages are an average based on a survey of research firms that that provide coverage for LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business earned $0.69 EPS. The company’s revenue was up .2% compared to the same quarter last year.
LPNT has been the topic of a number of recent research reports. BidaskClub raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research note on Friday, June 30th. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price objective on the stock in a research note on Thursday, July 13th. Morgan Stanley initiated coverage on shares of LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 price target on the stock. Barclays PLC raised their price target on shares of LifePoint Health from $58.00 to $60.00 and gave the company an “equal weight” rating in a research report on Monday, May 1st. Finally, Leerink Swann raised shares of LifePoint Health from a “market perform” rating to an “outperform” rating and raised their price target for the company from $73.00 to $74.00 in a research report on Tuesday, June 6th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the stock. LifePoint Health has an average rating of “Hold” and an average target price of $66.18.
Shares of LifePoint Health (LPNT) opened at 57.55 on Thursday. LifePoint Health has a 52 week low of $50.60 and a 52 week high of $70.95. The firm has a 50-day moving average of $63.64 and a 200 day moving average of $62.83. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of 12.89 and a beta of 0.86.
In related news, Chairman William F. Carpenter III sold 17,653 shares of the firm’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the completion of the sale, the chairman now owns 439,841 shares in the company, valued at $28,616,055.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the sale, the chairman now owns 504,535 shares of the company’s stock, valued at approximately $32,365,920.25. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares during the period. LS Investment Advisors LLC increased its stake in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares during the period. US Bancorp DE increased its stake in LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares during the period. Bank of Montreal Can increased its stake in LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares during the period. Finally, Teacher Retirement System of Texas bought a new stake in LifePoint Health during the first quarter worth about $210,000. Institutional investors and hedge funds own 99.27% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Zacks: Analysts Expect LifePoint Health, Inc. (LPNT) Will Announce Quarterly Sales of $1.60 Billion” was first published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/zacks-analysts-expect-lifepoint-health-inc-lpnt-will-announce-quarterly-sales-of-1-60-billion/1467141.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.